shr2554
Showing 1 - 5 of 5
Malignant Tumor Trial in Shanghai (SHR2554)
Completed
- Malignant Tumor
- SHR2554
-
Shanghai, Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Dec 16, 2022
Breast Cancer, Metastatic Cancer Trial in Shanghai (SHR7390, Famitinib, SHR3162)
Recruiting
- Breast Cancer
- Metastatic Cancer
- SHR7390
- +14 more
-
Shanghai, Shanghai, ChinaCancer Hospital Affiliated to Fudan University
Jul 22, 2022
Peripheral T Cell Lymphoma Trial in Shanghai (Azacitidine Injection, Dasatinib, Linperlisib)
Recruiting
- Peripheral T Cell Lymphoma
- Azacitidine Injection
- +6 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Nov 8, 2022
Prostate Cancer, Castration-resistant Prostate Cancer Trial in Shanghai (SHR3680, SHR2554)
Terminated
- Prostate Cancer
- Castration-resistant Prostate Cancer
- SHR3680
- SHR2554
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 2, 2021
Healthy Adult Subjects Trial in Henan (SHR2554)
Completed
- Healthy Adult Subjects
- SHR2554
-
Henan, ChinaHenan Cancer Hospital
Apr 2, 2020